The PINK1/Parkin-mediated mitophagy is triggered when PINK1 is stabilized on the outer membrane of damaged mitochondria and recruites Parkin, an E3 ubiquitin ligase, followed by ubiquitination of mitochondrial proteins, which are then recognized by autophagy receptors [41]
GSH , ,
By stabilizing mast cells and modulating the immune response, citrus bioflavonoids can potentially alleviate itching and redness, providing relief for eczema-prone skin
Also showed significant reductions in liver fat (up to 82.4%) and improvements in metabolic parameters Phase 3 (TRIUMPH-4) : The Phase 3 TRIUMPH-4 trial confirmed and exceeded Phase 2 results, demonstrating 28.7% mean weight loss at 68 weeks with the 12 mg dose -- the highest reported for any metabolic peptide in a Phase 3 trial Phase 3 program : Additional Phase 3 trials ongoing for obesity (TRIUMPH-1) and type 2 diabetes (TRANSCEND) MASLD/MASH : Specific trials underway evaluating liver-related endpoints Phase 3 TRIUMPH-4 data have confirmed the Phase 2 promise, though the full Phase 3 program across all indications is still ongoing
Arrabal-Polo MA, Arias-Santiago S, de Haro-Munoz T, Lopez-Ruiz A, Orgaz-Molina J, Gonzalez-Torres S,
